Intranasal Ketamine Versus Intranasal Fentanyl
Brief Summary
Abstract Background: Given the inadequate control of pain in patients with injury that refer to the emergency departments, the rapid onset of action of intranasal administration in pain management, and the avoidance of administering opioid medications, the present study aimed at evaluating the effect of intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients Materials and Methods: The current study was performed on 125 patients that were divided into the following three groups: control group (n = 41), 1 mg/kg intranasal ketamine group (n = 40), and 1μg/kg intranasal fentanyl group (n = 44). Then pain scores, HR, RR, BP, and SaO2 were recorded at baseline, 5, 10, 15, 30, and 40 minutes after the intervention.
Condition or Disease
- Multiple Trauma
- Pain, Acute
Phase
Study Design
Study type: | Interventional |
---|---|
Status: | Completed |
Study results: | No Results Available |
Age: | 15 Years to 65 Years (Child, Adult, Older Adult) |
Enrollment: | 125 () |
Funded by: | Other |
Masking |
Clinical Trial Dates
Start date: | Apr 01, 2017 | |
---|---|---|
Primary Completion: | Mar 20, 2018 | |
Completion Date: | Apr 15, 2018 | |
Study First Posted: | Jun 04, 2020 | |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Jun 04, 2020 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 15 |
Maximum Age: | 65 |
More Details
NCT Number: | NCT04414800 |
---|---|
Other IDs: | 396828 |
Study URL: | https://ClinicalTrials.gov/show/NCT04414800 |
Last updated: Mar 18, 2021